Evidence map›Paper›PMID 26832135›Full record

ArticleObesity surgery2016

A Genetic Risk Score Is Associated with Weight Loss Following Roux-en Y Gastric Bypass Surgery.

Marcus Bandstein, Sarah Voisin, Emil K Nilsson, Bernd Schultes, Barbara Ernst, Martin Thurnheer, Christian Benedict, Jessica Mwinyi, Helgi B Schiöth

Abstract read
In one paragraph

Article in Obesity surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Frontiers in endocrinology · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marcus BandsteinDepartment of Neuroscience, Functional Pharmacology, Uppsala University, Box 593, 751 24, Uppsala, Sweden. marcus.bandstein@neuro.uu.se.ORCID 0000-0002-7071-9067
Sarah VoisinDepartment of Neuroscience, Functional Pharmacology, Uppsala University, Box 593, 751 24, Uppsala, Sweden.
Emil K NilssonDepartment of Neuroscience, Functional Pharmacology, Uppsala University, Box 593, 751 24, Uppsala, Sweden.
Bernd SchultesInterdisciplinary Obesity Center, eSwiss Medical & Surgical Center, St. Gallen, Switzerland.
Barbara ErnstInterdisciplinary Obesity Center, eSwiss Medical & Surgical Center, St. Gallen, Switzerland.
Martin ThurnheerInterdisciplinary Obesity Center, eSwiss Medical & Surgical Center, St. Gallen, Switzerland.
Christian BenedictDepartment of Neuroscience, Functional Pharmacology, Uppsala University, Box 593, 751 24, Uppsala, Sweden.
Jessica MwinyiDepartment of Neuroscience, Functional Pharmacology, Uppsala University, Box 593, 751 24, Uppsala, Sweden.
Helgi B SchiöthDepartment of Neuroscience, Functional Pharmacology, Uppsala University, Box 593, 751 24, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurrently, Roux-en Y gastric bypass (RYGB) is the most efficient therapy for severe obesity. Weight loss after surgery is, however, highly variable and genetically influenced. Genome-wide association studies have identified several single nucleotide polymorphisms (SNP) associated with body mass index (BMI) and waist-hip ratio (WHR). We aimed to identify two genetic risk scores (GRS) composed of weighted BMI and WHR-associated SNPs to estimate their impact on excess BMI loss (EBMIL) after RYGB surgery.

methodsTwo hundred and thirty-eight obese patients (BMI 45.1 ± 6.2 kg/m(2), 74 % women), who underwent RYGB, were genotyped for 35 BMI and WHR-associated SNPs and were followed up after 2 years. SNPs with high impact on post-surgical weight loss were filtered out using a random forest model. The filtered SNPs were combined into a GRS and analyzed in a linear regression model.

resultsAn up to 11 % lower EBMIL with higher risk score was estimated for two GRS models (P = 0.026 resp. P = 0.021) composed of seven BMI-associated SNPs (closest genes: MC4R, TMEM160, PTBP2, NUDT3, TFAP2B, ZNF608, MAP2K5, GNPDA2, and MTCH2) and of three WHR-associated SNPs (closest genes: HOXC13, LYPLAL1, and DNM3-PIGC). Patients within the lowest GRS quartile had higher EBMIL compared to patients within the other three quartiles in both models.

conclusionsWe identified two GRSs composed of BMI and WHR-associated SNPs with significant impact on weight loss after RYGB surgery using random forest analysis as a SNP selection tool. The GRS may be useful to pre-surgically evaluate the risks for patients undergoing RYGB surgery.

Indexed as

Obesity, MorbidBody Mass IndexFemaleGastric BypassGenome-Wide Association StudyHumansMalePolymorphism, Single NucleotideRisk FactorsWaist-Hip RatioWeight LossGenetic risk scoreObesityPost-operative weight lossRandom forest modelRoux-en Y gastric bypass surgery

Identifiers

PMID26832135
PMCPMC4985537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.